Gilead Sciences (GILD)
(Delayed Data from NSDQ)
$65.42 USD
+0.15 (0.23%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $65.42 0.00 (0.00%) 5:58 PM ET
4-Sell of 5 4
B Value D Growth F Momentum C VGM
Income Statements
Fiscal Year end for Gilead Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 27,116 | 27,281 | 27,305 | 24,689 | 22,449 |
Cost Of Goods | 6,498 | 5,657 | 6,601 | 4,572 | 4,675 |
Gross Profit | 20,618 | 21,624 | 20,704 | 20,117 | 17,774 |
Selling & Adminstrative & Depr. & Amort Expenses | 13,013 | 14,294 | 10,786 | 16,046 | 13,487 |
Income After Depreciation & Amortization | 7,605 | 7,330 | 9,918 | 4,071 | 4,287 |
Non-Operating Income | 198 | -581 | -639 | -1,418 | 1,868 |
Interest Expense | 944 | 935 | 1,001 | 984 | 995 |
Pretax Income | 6,859 | 5,814 | 8,278 | 1,669 | 5,160 |
Income Taxes | 1,247 | 1,248 | 2,077 | 1,580 | -204 |
Minority Interest | -52 | -26 | -24 | -34 | -22 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,612 | 4,566 | 6,201 | 89 | 5,364 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,665 | 4,592 | 6,225 | 123 | 5,386 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 10,298 | 9,433 | 11,968 | 5,551 | 5,691 |
Depreciation & Amortization (Cash Flow) | 2,693 | 2,103 | 2,050 | 1,480 | 1,404 |
Income After Depreciation & Amortization | 7,605 | 7,330 | 9,918 | 4,071 | 4,287 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 1,258.00 | 1,262.00 | 1,262.00 | 1,263.00 | 1,277.00 |
Diluted EPS Before Non-Recurring Items | 6.72 | 7.26 | 7.28 | 7.09 | 6.14 |
Diluted Net EPS (GAAP) | 4.50 | 3.64 | 4.93 | 0.10 | 4.22 |
Fiscal Year end for Gilead Sciences, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 7,114.00 | 7,051.00 | 6,599.00 | 6,352.00 |
Cost Of Goods | NA | 2,090.00 | 1,565.00 | 1,442.00 | 1,401.00 |
Gross Profit | NA | 5,024.00 | 5,486.00 | 5,157.00 | 4,951.00 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3,411.00 | 2,863.00 | 3,492.00 | 3,247.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1,613.00 | 2,623.00 | 1,665.00 | 1,704.00 |
Non-Operating Income | NA | 292.00 | -72.00 | 152.00 | -174.00 |
Interest Expense | NA | 252.00 | 232.00 | 230.00 | 230.00 |
Pretax Income | NA | 1,653.00 | 2,318.00 | 1,588.00 | 1,300.00 |
Income Taxes | NA | 236.00 | 146.00 | 549.00 | 316.00 |
Minority Interest | NA | -12.00 | -8.00 | -6.00 | -26.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1,417.00 | 2,172.00 | 1,039.00 | 984.00 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1,429.00 | 2,180.00 | 1,045.00 | 1,011.00 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 1,256.00 | 1,257.00 | 1,258.00 | 1,261.00 |
Diluted EPS Before Non-Recurring Items | NA | 1.72 | 2.29 | 1.34 | 1.37 |
Diluted Net EPS (GAAP) | NA | 1.14 | 1.73 | 0.83 | 0.80 |